These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 25450422)

  • 1. Use of ondansetron during pregnancy and congenital malformations in the infant.
    Danielsson B; Wikner BN; Källén B
    Reprod Toxicol; 2014 Dec; 50():134-7. PubMed ID: 25450422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Maternal First-Trimester Ondansetron Use With Cardiac Malformations and Oral Clefts in Offspring.
    Huybrechts KF; Hernández-Díaz S; Straub L; Gray KJ; Zhu Y; Patorno E; Desai RJ; Mogun H; Bateman BT
    JAMA; 2018 Dec; 320(23):2429-2437. PubMed ID: 30561479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ondansetron in pregnancy and risk of adverse fetal outcomes.
    Pasternak B; Svanström H; Hviid A
    N Engl J Med; 2013 Feb; 368(9):814-23. PubMed ID: 23445092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ondansetron for Treatment of Nausea and Vomiting of Pregnancy and the Risk of Specific Birth Defects.
    Parker SE; Van Bennekom C; Anderka M; Mitchell AA;
    Obstet Gynecol; 2018 Aug; 132(2):385-394. PubMed ID: 29995744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First trimester ondansetron exposure and risk of structural birth defects.
    Zambelli-Weiner A; Via C; Yuen M; Weiner DJ; Kirby RS
    Reprod Toxicol; 2019 Jan; 83():14-20. PubMed ID: 30385129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ondansetron Use in Pregnancy and Birth Defects: A Systematic Review.
    Carstairs SD
    Obstet Gynecol; 2016 May; 127(5):878-883. PubMed ID: 27054939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal use of antipsychotics in early pregnancy and delivery outcome.
    Reis M; Källén B
    J Clin Psychopharmacol; 2008 Jun; 28(3):279-88. PubMed ID: 18480684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Pregnancy Outcomes of Patients Treated With Ondansetron vs Alternative Antiemetic Medications in a Multinational, Population-Based Cohort.
    Dormuth CR; Winquist B; Fisher A; Wu F; Reynier P; Suissa S; Dahl M; Ma Z; Lu X; Zhang J; Raymond CB; Filion KB; Platt RW; Moriello C; Paterson JM;
    JAMA Netw Open; 2021 Apr; 4(4):e215329. PubMed ID: 33890993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery outcome after the use of meclozine in early pregnancy.
    Källén B; Mottet I
    Eur J Epidemiol; 2003; 18(7):665-9. PubMed ID: 12952140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of malformation after ondansetron in pregnancy: An updated systematic review and meta-analysis.
    Picot C; Berard A; Grenet G; Ripoche E; Cucherat M; Cottin J
    Birth Defects Res; 2020 Aug; 112(13):996-1013. PubMed ID: 32420702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal obstruction is a rare complication of ondansetron exposure in hyperemesis gravidarum.
    Fejzo MS; MacGibbon K; Mullin P
    Reprod Toxicol; 2015 Nov; 57():207. PubMed ID: 26196894
    [No Abstract]   [Full Text] [Related]  

  • 12. Ondansetron Use During Pregnancy: Birth Defects and Obstetric Outcomes.
    Masarwe S; Shvartsur R; Hadar E; Betesh-Abay B; Peleg N; Azab AN
    Clin Nurs Res; 2023 May; 32(4):705-711. PubMed ID: 36912091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal obstruction in pregnancy by ondansetron.
    Cohen R; Shlomo M; Dil DN; Dinavitser N; Berkovitch M; Koren G
    Reprod Toxicol; 2014 Dec; 50():152-3. PubMed ID: 25461913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study.
    Einarson A; Maltepe C; Navioz Y; Kennedy D; Tan MP; Koren G
    BJOG; 2004 Sep; 111(9):940-3. PubMed ID: 15327608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ondansetron in Pregnancy and the Risk of Congenital Malformations: A Systematic Review.
    Lavecchia M; Chari R; Campbell S; Ross S
    J Obstet Gynaecol Can; 2018 Jul; 40(7):910-918. PubMed ID: 29754832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of anti-asthmatic drugs during pregnancy. 3. Congenital malformations in the infants.
    Källén B; Otterblad Olausson P
    Eur J Clin Pharmacol; 2007 Apr; 63(4):383-8. PubMed ID: 17279357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous Ondansetron in Pregnancy and Risk of Congenital Malformations.
    Huybrechts KF; Hernandez-Diaz S; Straub L; Gray KJ; Zhu Y; Mogun H; Bateman BT
    JAMA; 2020 Jan; 323(4):372-374. PubMed ID: 31730152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major Congenital Malformation Risk After First Trimester Gestational Exposure to Oral or Intravenous Ondansetron.
    Andrade C
    J Clin Psychiatry; 2020 Jun; 81(3):. PubMed ID: 32526103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal use of 5-aminosalicylates in early pregnancy and congenital malformation risk in the offspring.
    Källén B
    Scand J Gastroenterol; 2014 Apr; 49(4):442-8. PubMed ID: 24443767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of antiemetic drugs during pregnancy in Sweden.
    Asker C; Norstedt Wikner B; Källén B
    Eur J Clin Pharmacol; 2005 Dec; 61(12):899-906. PubMed ID: 16328314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.